Diabetes
|
Participants randomized to exercise
|
No |
90 |
344.64 (95.69) |
369.88 (90.96) |
25.24 (12.53, 37.95) |
Reference |
0.7043 |
Yes |
51 |
323.48 (94.98) |
352.78 (86.08) |
29.30 (12.42, 46.19) |
4.07 (−17.07, 25.20) |
|
Participants randomized to control
|
No |
87 |
345.48 (91.75) |
340.77 (103.27) |
−4.71 (−17.57, 8.16) |
Reference |
0.3414 |
Yes |
55 |
320.69 (92.66) |
306.01 (95.05) |
−14.69 (−30.86, 1.49) |
−9.98 (−30.65, 10.69) |
|
Coronary artery disease
|
Participants randomized to exercise
|
No |
97 |
348.03 (95.13) |
377.05 (80.97) |
29.02 (16.79, 41.25) |
Reference |
0.5042 |
Yes |
44 |
312.65 (93.27) |
334.25 (100.18) |
21.61 (3.45, 37.77) |
−7.42 (−29.31, 14.48) |
|
Participants randomized to control
|
No |
106 |
338.60 (91.89) |
327.44 (101.38) |
−11.15 (−22.81, 0.51) |
Reference |
0.3858 |
Yes |
36 |
327.86 (95.40) |
326.90 (102.35) |
−0.97 (−20.97, 19.04) |
10.19 (−12.97, 33.35) |
|
Pulmonary disease
|
Participants randomized to exercise
|
No |
128 |
340.13 (94.78) |
364.15 (88.77) |
24.02 (13.46, 34.59) |
Reference |
0.1003 |
Yes |
13 |
306.07 (102.45) |
359.20 (98.00) |
53.13 (19.99, 86.27) |
29.10 (−5.68, 63.89) |
|
Participants randomized to control
|
No |
122 |
339.19 (95.47) |
329.47 (105.63) |
−9.72 (−20.68, 1.23) |
Reference |
0.6458 |
Yes |
18 |
315.01 (73.40) |
312.40 (72.68) |
−2.61 (−31.12, 25.91) |
7.12 (−23.43, 37.66) |
|
Heart failure
|
Participants randomized to exercise
|
No |
129 |
336.88 (95.07) |
364.46 (89.73) |
27.58 (16.98, 38.18) |
Reference |
0.2952 |
Yes |
10 |
364.54 (95.46) |
371.12 (86.85) |
6.58 (−31.49, 44.65) |
−21.00 (−60.52, 18.52) |
|
Participants randomized to control
|
No |
122 |
340.26 (94.36) |
328.99 (104.40) |
−11.27 (−22.10, −0.44) |
Reference |
0.1910 |
Yes |
20 |
309.11 (77.51) |
317.02 (80.93) |
7.91 (−18.84, 34.66) |
19.18 (−9.68, 48.04) |
|
Symptoms of classic intermittent claudication
|
Participants randomized to exercise
|
No |
90 |
335.65 (96.76) |
364.28 (87.69) |
28.63 (15.92, 41.34) |
Reference |
0.6196 |
Yes |
51 |
339.34 (94.54) |
362.66 (92.94) |
23.31 (6.43, 40.19) |
−5.32 (−26.45, 15.81) |
|
Participants randomized to control
|
No |
98 |
337.71 (95.71) |
327.62 (105.07) |
−10.09 (−22.24, 2.06) |
Reference |
0.6584 |
Yes |
44 |
331.80 (86.08) |
326.61 (93.38) |
−5.20 (−23.33, 12.94) |
4.89 (−16.94, 26.72) |
|
Asymptomatic (no exertional leg symptoms)
|
Participants randomized to exercise
|
No |
133 |
333.81 (94.36) |
361.64 (88.79) |
27.83 (17.40, 38.26) |
Reference |
0.3741 |
Yes |
8 |
389.72 (108.00) |
397.80 (96.95) |
8.08 (−34.46, 50.62) |
−19.75 (−63.55, 24.05) |
|
Participants randomized to control
|
No |
136 |
334.68 (93.15) |
326.90 (102.42) |
−7.78 (−18.08, 2.52) |
Reference |
0.4597 |
Yes |
6 |
362.97 (80.33) |
336.40 (76.34) |
−26.57 (−75.61, 22.47) |
−18.79 (−68.90, 31.32) |
|